Additionally, Indo5, selectively abrogating HGF-induced c-Met pathway activation and brain-derived neurotrophic factor (BDNF)/nerve growth factor (NDF)-induced Trks signaling activation, significantly inhibits HCC tumor growth in xenograft mice (Luo et al., 2019). This evidence concerns the gene MET and neoplasm.